#NeurotrophicKeratitis: Diagnosis, Management, and Future Directions: crstoday.com/articles/jan...
Clinical trials of #KPI-012, a mesenchymal stem cell–derived #secretometherapy that enhances #cornealhealing by delivering bioactive molecules. If approved, the drug could revolutionize #NK treatment.
0
0
0
0